Invenra Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 38
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $640K
Latest Deal Amount
  • Investors
  • 7

Invenra General Information

Description

Provider of a drug discovery platform intended to help discover and optimize human multi-specific antibodies. The company's platform is used to discover and develop new biologic drugs for cancer, Alzheimer's disease and diabetes, enabling healthcare institutes to optimize bispecific formatting, binding affinities, candidate pairings and linkers in biologically relevant assays.

Contact Information

Website
www.invenra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 505 South Rosa Road
  • Suite 235
  • Madison, WI 53719
  • United States
+1 (608) 000-0000

Invenra Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Invenra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - PPP 10-Apr-2020 $640K 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 16-Oct-2018 00.000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 03-Oct-2017 00.000 000.00 000.00 Completed Generating Revenue
5. Early Stage VC 18-Jul-2016 00.000 000.00 Completed Startup
4. Early Stage VC 27-Jan-2015 00.000 000.00 0000 Completed Startup
3. Early Stage VC 000 00.00 Completed Startup
2. Early Stage VC 19-Feb-2013 $3M $4.2M Completed Startup
1. Early Stage VC 18-Jan-2012 $1.2M $1.2M Completed Startup
To view Invenra’s complete valuation and funding history, request access »

Invenra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Invenra’s complete cap table history, request access »

Invenra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of a drug discovery platform intended to help discover and optimize human multi-specific antibodies. The compan
Drug Discovery
Madison, WI
38 As of 2021
000.00
000000000 - 000.00

000000 0

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000000000000
Oxford, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Invenra Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000 Venture Capital-Backed Oxford, United Kingdom 00 000.00 000000000000 000.00
000000 00000000000 Formerly VC-backed Watertown, MA 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed Princeton, NJ 0 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 31 competitors. Get the full list »

Invenra Executive Team (7)

Name Title Board Seat Contact Info
Roland Green Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Bonnie Hammer Ph.D Vice President, Biologics Development
Emile Nuwaysir Ph.D Co-Founder & Vice Chairman
You’re viewing 3 of 7 executive team members. Get the full list »

Invenra Board Members (6)

Name Representing Role Since
David Snyder Self Board Member 000 0000
Emile Nuwaysir Ph.D Self Co-Founder & Vice Chairman 000 0000
Paul Weiss Ph.D Venture Investors Board Member 000 0000
Richard Lesniewski Ph.D Self Board Member 000 0000
Roland Green Ph.D Invenra Co-Founder, President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Invenra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invenra Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
State of Wisconsin Investment Board Government Minority 000 0000 000000 0
Venture Investors Venture Capital Minority 000 0000 000000 0
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0
New Capital Fund Venture Capital Minority 000 0000 000000 0
Venture Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »